C7243

Chicoric Acid

≥95% (HPLC)

• Synonim(y): 2,3-Dicaffeoyl-L-tartaric acid, Cichoric acid
• Wzór empiryczny (zapis Hilla): C₂₂H₁₈O₁₂
• Numer CAS: 6537-80-0
• Masa cząsteczkowa: 474.37
• NACRES: NA.77
• PubChem Substance ID: 329775142
• MDL number: MFCD22683653
• UNSPSC Code: 12352106
• Assay: ≥95% (HPLC)
• Form: powder

Właściwości

• Quality Segment: 200
• assay: ≥95% (HPLC)
• form: powder
• storage temp.: −20°C
• SMILES string: OC1=CC=C(/C=C/C(O[C@@H](C(O)=O)[C@H](C(O)=O)OC(/C=C/C2=CC(O)=C(O)C=C2)=O)=O)C=C1O
• InChI: 1S/C22H18O12/c23-13-5-1-11(9-15(13)25)3-7-17(27)33-19(21(29)30)20(22(31)32)34-18(28)8-4-12-2-6-14(24)16(26)10-12/h1-10,19-20,23-26H,(H,29,30)(H,31,32)/b7-3+,8-4+/t19-,20-/m1/s1
• InChI key: YDDGKXBLOXEEMN-IABMMNSOSA-N

Opis

Application

• Pharmacokinetics and antioxidant activity of dihydrocaffeic acid grafted chitosan nanomicelles loaded with chicoric acid in broilers.: This study investigates the pharmacokinetics and antioxidant properties of chicoric acid-loaded nanomicelles in broilers, highlighting its potential for improving poultry health (Ren et al., 2024).


• Screening of the effective sites of Cichorium glandulosum against hyperuricemia combined with hyperlipidemia and its network pharmacology analysis.: The research identifies effective components in Cichorium glandulosum, including chicoric acid, for treating hyperuricemia and hyperlipidemia using network pharmacology methods (Yang et al., 2024).

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS08,GHS07
• signalword: Danger
• hcodes: H302,H317,H334
• pcodes: P280 - P301 + P312 + P330 - P302 + P352
• Hazard Classifications: Acute Tox. 4 Oral - Resp. Sens. 1 - Skin Sens. 1
• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Faceshields, Gloves